Professional Summary
Education & Certifications
- Residency: University of Minnesota School of Medicine (1979) MN
- Internship: University of Minnesota School of Medicine (1978) MN
- Medical Education: Columbia Presbyterian Pediatric Residency Program (1977) NY
- Fellowship: Memorial Sloan-Kettering Cancer Center (1984) NY
- Board Certification: American Board of Psychiatry and Neurology, Neurology (1983)
- Residency: New York Presbyterian Hospital (1982) NY
- M.D., Columbia College of P&S, Medicine (1977)
Publications
-
Prevention and treatment of central nervous system involvement by non-Hodgkin's lymphoma: A review of the literature
Colocci, N., Glantz, M., & Recht, L. (2004). Prevention and treatment of central nervous system involvement by non-Hodgkin's lymphoma: A review of the literature. SEMINARS IN NEUROLOGY, 24(4), 395–404. -
Treatment of neoplastic meningitis: what is the standard of care?
Recht, L., & Phuphanich, S. (2004). Treatment of neoplastic meningitis: what is the standard of care? Expert Review of Neurotherapeutics, 4(4), S11–7. -
Amplification of whole tumor genomes and geneby-gene mapping of genomic aberrations from limited sources of fresh-frozen and paraffin-embedded DNA
Bredel, M., Bredel, C., Juric, D., Kim, Y., Vogel, H., Harsh, G. R., … Sikic, B. I. (2005). Amplification of whole tumor genomes and geneby-gene mapping of genomic aberrations from limited sources of fresh-frozen and paraffin-embedded DNA. JOURNAL OF MOLECULAR DIAGNOSTICS, 7(2), 171–82. -
High-resolution genome-wide mapping of genetic alterations in human glial brain tumors
Bredel, M., Bredel, C., Juric, D., Harsh, G. R., Vogel, H., Recht, L. D., & Sikic, B. I. (2005). High-resolution genome-wide mapping of genetic alterations in human glial brain tumors. CANCER RESEARCH, 65(10), 4088–96. -
Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas
Bredel, M., Bredel, C., Juric, D., Harsh, G. R., Vogel, H., Recht, L. D., & Sikic, B. I. (2005). Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. CANCER RESEARCH, 65(19), 8679–89. -
Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappa B-mediated resistance to O-6-alkylating agents in human glioblastomas
Bredel, M., Bredel, C., Juric, D., Duran, G. E., Yu, R. X., Harsh, G. R., … Sikic, B. I. (2006). Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappa B-mediated resistance to O-6-alkylating agents in human glioblastomas. JOURNAL OF CLINICAL ONCOLOGY, 24(2), 274–87. -
Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea
Jang, T. C., Savarese, T., Low, H. P., Kim, S., Vogel, H., Lapointe, D., … Recht, L. (2006). Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea. AMERICAN JOURNAL OF PATHOLOGY, 168(5), 1676–85. -
Optimizing therapy for patients with brain metastases
Kuo, T., & Recht, L. (2006). Optimizing therapy for patients with brain metastases. SEMINARS IN ONCOLOGY, 33(3), 299–306. -
A distinct phenotypic change in gliomas at the time of magnetic resonance imaging detection
Jang, T., Sathy, B., Hsu, Y.-H., Merchant, M., Recht, B., Chang, C., & Recht, L. (2008). A distinct phenotypic change in gliomas at the time of magnetic resonance imaging detection. JOURNAL OF NEUROSURGERY, 108(4), 782–790. -
Murine Embryonic Stem Cell-Derived Pyramidal Neurons Integrate into the Cerebral Cortex and Appropriately Project Axons to Subcortical Targets
Ideguchi, M., Palmer, T. D., Recht, L. D., & Weimann, J. M. (2010). Murine Embryonic Stem Cell-Derived Pyramidal Neurons Integrate into the Cerebral Cortex and Appropriately Project Axons to Subcortical Targets. JOURNAL OF NEUROSCIENCE, 30(3), 894–904. -
Treatment and Prevention of Secondary CNS Lymphoma
Nagpal, S., Glantz, M. J., & Recht, L. (2010). Treatment and Prevention of Secondary CNS Lymphoma. SEMINARS IN NEUROLOGY, 30(3), 263–272. -
5 '-AMP-activated protein kinase activity is elevated early during primary brain tumor development in the rat
Jang, T., Calaoagan, J. M., Kwon, E., Samuelsson, S., Recht, L., & Laderoute, K. R. (2011). 5 '-AMP-activated protein kinase activity is elevated early during primary brain tumor development in the rat. INTERNATIONAL JOURNAL OF CANCER, 128(9), 2230–39. -
Time-lapse imaging of disease progression in deep brain areas using fluorescence microendoscopy
Barretto, R. P. J., Ko, T. H., Jung, J. C., Wang, T. J., Capps, G., Waters, A. C., … Schnitzer, M. J. (2011). Time-lapse imaging of disease progression in deep brain areas using fluorescence microendoscopy. NATURE MEDICINE, 17(2), 223–U120. -
Treatment and Prophylaxis of Hematologic Malignancy in the Central Nervous System
Nagpal, S., & Recht, L. (2011). Treatment and Prophylaxis of Hematologic Malignancy in the Central Nervous System. CURRENT TREATMENT OPTIONS IN NEUROLOGY, 13(4), 400–412. -
Chemerin158K Protein Is the Dominant Chemerin Isoform in Synovial and Cerebrospinal Fluids but Not in Plasma
Zhao, L., Yamaguchi, Y., Sharif, S., Du, X.-Y., Song, J. J., Lee, D. M., … Leung, L. L. K. (2011). Chemerin158K Protein Is the Dominant Chemerin Isoform in Synovial and Cerebrospinal Fluids but Not in Plasma. JOURNAL OF BIOLOGICAL CHEMISTRY, 286(45), 39520–27. -
Bevacizumab improves quality of life in patients with recurrent glioblastoma.
Nagpal, S., Harsh, G., & Recht, L. (2011). Bevacizumab improves quality of life in patients with recurrent glioblastoma. Chemotherapy Research and Practice, 2011, 602812-? -
Metabolite kinetics in C6 rat glioma model using magnetic resonance spectroscopic imaging of hyperpolarized [1-13C]pyruvate
Park, J. M., Josan, S., Jang, T., Merchant, M., Yen, Y.-F., Hurd, R. E., … Mayer, D. (2012). Metabolite kinetics in C6 rat glioma model using magnetic resonance spectroscopic imaging of hyperpolarized [1-13C]pyruvate. MAGNETIC RESONANCE IN MEDICINE, 68(6), 1886–93. -
Alterations in Cerebrospinal Fluid Proteins in a Presymptomatic Primary Glioma Model
Whitin, J. C., Jang, T., Merchant, M., Yu, T. T. S., Lau, K., Recht, B., … Recht, L. (2012). Alterations in Cerebrospinal Fluid Proteins in a Presymptomatic Primary Glioma Model. PLOS ONE, 7(11). -
Thrombin-cleaved Fragments of Osteopontin Are Overexpressed in Malignant Glial Tumors and Provide a Molecular Niche with Survival Advantage
Yamaguchi, Y., Shao, Z., Sharif, S., Du, X.-Y., Myles, T., Merchant, M., … Leung, L. L. K. (2013). Thrombin-cleaved Fragments of Osteopontin Are Overexpressed in Malignant Glial Tumors and Provide a Molecular Niche with Survival Advantage. JOURNAL OF BIOLOGICAL CHEMISTRY, 288(5), 3097–3111. -
Advances in the management of glioblastoma: the role of temozolomide and MGMT testing.
Thomas, R. P., Recht, L., & Nagpal, S. (2013). Advances in the management of glioblastoma: the role of temozolomide and MGMT testing. Clinical Pharmacology : Advances and Applications, 5, 1–9. -
Metabolic response of glioma to dichloroacetate measured in vivo by hyperpolarized C-13 magnetic resonance spectroscopic imaging
Park, J. M., Recht, L. D., Josan, S., Merchant, M., Jang, T., Yen, Y.-F., … Mayer, D. (2013). Metabolic response of glioma to dichloroacetate measured in vivo by hyperpolarized C-13 magnetic resonance spectroscopic imaging. NEURO-ONCOLOGY, 15(4), 433–41. -
Steroid-Sparing Effect of Corticorelin Acetate in Peritumoral Cerebral Edema Is Associated With Improvement in Steroid-Induced Myopathy
Recht, L., Mechtler, L. L., Wong, E. T., O'Connor, P. C., & Rodda, B. E. (2013). Steroid-Sparing Effect of Corticorelin Acetate in Peritumoral Cerebral Edema Is Associated With Improvement in Steroid-Induced Myopathy. JOURNAL OF CLINICAL ONCOLOGY, 31(9), 1182–87. -
Simultaneous perfusion and permeability measurements using combined spin- and gradient-echo MRI.
Schmiedeskamp, H., Andre, J. B., Straka, M., Christen, T., Nagpal, S., Recht, L., … Bammer, R. (2013). Simultaneous perfusion and permeability measurements using combined spin- and gradient-echo MRI. Journal of Cerebral Blood Flow and Metabolism , 33(5), 732–43. -
ETIRINOTECAN PEGOL DNA Topoisomerase 1 Inhibitor Oncolytic
Nagpal, S., & Recht, L. D. (2013). ETIRINOTECAN PEGOL DNA Topoisomerase 1 Inhibitor Oncolytic. DRUGS OF THE FUTURE, 38(4), 227–233. -
MOTEXAFIN GADOLINIUM COMBINED WITH PROMPT WHOLE BRAIN RADIOTHERAPY PROLONGS TIME TO NEUROLOGIC PROGRESSION IN NON-SMALL-CELL LUNG CANCER PATIENTS WITH BRAIN METASTASES: RESULTS OF A PHASE III TRIAL
Mehta, M. P., Shapiro, W. R., Phan, S. C., Gervais, R., Carrie, C., Chabot, P., … Renschler, M. F. (2009). MOTEXAFIN GADOLINIUM COMBINED WITH PROMPT WHOLE BRAIN RADIOTHERAPY PROLONGS TIME TO NEUROLOGIC PROGRESSION IN NON-SMALL-CELL LUNG CANCER PATIENTS WITH BRAIN METASTASES: RESULTS OF A PHASE III TRIAL. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 73(4), 1069–76. -
VERUBULIN HYDROCHLORIDE Apoptosis Inducer Vascular Disrupting Agent Oncolytic
Thomas, P., & Recht, L. (2010). VERUBULIN HYDROCHLORIDE Apoptosis Inducer Vascular Disrupting Agent Oncolytic. DRUGS OF THE FUTURE, 35(12), 993–997. -
Isolation of immortalized, INK4a/ARF-deficient cells from the subventricular zone after in utero N-ethyl-N-nitrosourea exposure
Savarese, T. M., Jang, T., Low, H. P., Salmonsen, R., Litofsky, N. S., Matijasevic, Z., … Recht, L. D. (2005). Isolation of immortalized, INK4a/ARF-deficient cells from the subventricular zone after in utero N-ethyl-N-nitrosourea exposure. JOURNAL OF NEUROSURGERY, 102(1), 98–108. -
EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors
Li, L., Dutra, A., Pak, E., Labrie, J. E., Gerstein, R. M., Pandolfi, P. P., … Ross, A. H. (2009). EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors. NEURO-ONCOLOGY, 11(1), 9–21. -
Preliminary use of differential scanning calorimetry of cerebrospinal fluid for the diagnosis of glioblastoma multiforme
Chagovetz, A. A., Jensen, R. L., Recht, L., Glantz, M., & Chagovetz, A. M. (2011). Preliminary use of differential scanning calorimetry of cerebrospinal fluid for the diagnosis of glioblastoma multiforme. JOURNAL OF NEURO-ONCOLOGY, 105(3), 499–506. -
Understanding the Origins of Gliomas and Developing Novel Therapies: Cerebrospinal Fluid and Subventricular Zone Interplay
Glantz, M., Kesari, S., Recht, L., Fleischhack, G., & Van Horn, A. (2009). Understanding the Origins of Gliomas and Developing Novel Therapies: Cerebrospinal Fluid and Subventricular Zone Interplay. SEMINARS IN ONCOLOGY, 36(4), S17–S24. -
Gender Disparity in the Rate of Partner Abandonment in Patients With Serious Medical Illness
Glantz, M. J., Chamberlain, M. C., Liu, Q., Hsieh, C.-C., Edwards, K. R., Van Horn, A., & Recht, L. (2009). Gender Disparity in the Rate of Partner Abandonment in Patients With Serious Medical Illness. CANCER, 115(22), 5237–42. -
Aberrant nestin expression during ethylnitrosourea-(ENU)-induced neurocarcinogenesis
Jang, T. C., Litofsky, N. S., Smith, T. W., Ross, A. H., & Recht, L. D. (2004). Aberrant nestin expression during ethylnitrosourea-(ENU)-induced neurocarcinogenesis. NEUROBIOLOGY OF DISEASE, 15(3), 544–552. -
Differentiation prevents assessment of neural stem cell pluripotency after blastocyst injection
Greco, B., Low, H. P., Johnson, E. C., Salmonsen, R. A., Gallant, J., Jones, S. N., … Recht, L. D. (2004). Differentiation prevents assessment of neural stem cell pluripotency after blastocyst injection. STEM CELLS, 22(4), 600–608. -
Central Nervous System Cancers
Brem, S. S., Bierman, P. J., Brem, H., Butowski, N., Chamberlain, M. C., Chiocca, E. A., … Wen, P. Y. (2011). Central Nervous System Cancers. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 9(4), 352–400. -
Embryonic stem cell rescue of tremor and ataxia in myelin-deficient shiverer mice
Low, H. P., Greco, B., Tanahashi, Y., Gallant, J., Jones, S. N., Billings-Gagliardi, S., … Schwartz, W. J. (2009). Embryonic stem cell rescue of tremor and ataxia in myelin-deficient shiverer mice. JOURNAL OF THE NEUROLOGICAL SCIENCES, 276(1-2), 133–137. -
Central Nervous System Cancers Clinical Practice Guidelines in Oncology
Nabors, L. B., Ammirati, M., Bierman, P. J., Brem, H., Butowski, N., Chamberlain, M. C., … Ho, M. (2013). Central Nervous System Cancers Clinical Practice Guidelines in Oncology. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 11(9), 1114–1151. -
Visualization of rodent brain tumor angiogenesis and effects of antiangiogenic treatment using 3D Delta R-2-mu MRA
Lin, C.-Y., Siow, T. Y., Lin, M.-H., Hsu, Y.-H., Tung, Y.-Y., Jang, T., … Chang, C. (2013). Visualization of rodent brain tumor angiogenesis and effects of antiangiogenic treatment using 3D Delta R-2-mu MRA. ANGIOGENESIS, 16(4), 785–793. -
Visualization of rodent brain tumor angiogenesis and effects of antiangiogenic treatment using 3D Delta R-2-mu MRA
Lin, C.-Y., Siow, T. Y., Lin, M.-H., Hsu, Y.-H., Tung, Y.-Y., Jang, T., … Chang, C. (2013). Visualization of rodent brain tumor angiogenesis and effects of antiangiogenic treatment using 3D Delta R-2-mu MRA. ANGIOGENESIS, 16(4), 785–793.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
- Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma »
- A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme »
- Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme »
- Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme »
- A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma »
- Phase 2 Study MPC-6827 for Recurrent Glioblastoma Multiforme »
- Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma »
- Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma »
Practice Locations
Brain and Spine Tumor Center at Stanford Cancer Center Palo Alto, CA
Palo Alto, CABrain and Spine Tumor Center at Stanford Cancer Center
875 Blake Wilbur Drive
Palo Alto , CA 94304
Make An Appointment More Clinic Information » Getting Here »Neurogenetic Cancer Palo Alto, CA
Palo Alto, CANeurogenetic Cancer
213 Quarry Road
Palo Alto , CA 94304
Make An Appointment More Clinic Information » Getting Here »Important Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Patient Reviews
(95 reviews)
View More »
Referring Physicians
PHYSICIAN HELPLINE
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records